Palisade Bio shares are trading lower after the company announced $2 million registered direct offering.
Portfolio Pulse from Benzinga Newsdesk
Palisade Bio has announced a $2 million registered direct offering, leading to a decrease in its share price.

September 07, 2023 | 1:19 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Palisade Bio's stock price is expected to decrease in the short term due to the announcement of a $2 million registered direct offering.
The announcement of a registered direct offering often leads to a decrease in a company's stock price. This is because it increases the number of shares available in the market, diluting the value of existing shares. In this case, Palisade Bio's announcement of a $2 million registered direct offering has led to a decrease in its share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100